4
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Acid and Pepsin Secretion in Patients with Esophagitis Refractory to Treatment with H2 Antagonists

Pages 449-452 | Received 07 Oct 1991, Accepted 13 Jan 1992, Published online: 08 Jul 2009

References

  • Tytgat G NJ, Nicolai J J, Reman F C. Efficacy of different doses of cimetidine in the treatment of reflux esophagitis. A review of three large, double-blind, controlled trials. Gastroenterology 1990; 99: 629–34
  • Koclz H R, Birchler R, Bretholz A, et al. Healing and relapse of reflux esophagitis during treatment with ranitidine. Gastroenterology 1986; 91: 1198–205
  • Klinkenberg-Knol E C, Jansen J B, Lamers C B, Nelis F, Meu-Wissen S GM. Temporary cessation of long-term maintenance treatment with omeprazole in patients with H2-receptor-antag-onist-resistant reflux esophagitis. Effects on symptoms, endoscopy, serum gastrin, and gastric acid output. Scand J Gastroenterol 1990; 25: 1144–50
  • Lanzon Miller E, Pounder R E, Hamilton M R, et al. 24-hr intragastric acidity. Aliment Pharmacol Ther 1987; 1: 239–52
  • Robinson M G, Humphries T J, McIntosh D, Allen M L, Cagliola A J, Bradstreet T E. Omeprazole (OME) dose response effect on 24-hour esophageal acid exposure in patients with symptomatic gastroesophageal reflux disease (GERD): a four-way crossover study. Gastroenterology 1989; 96: A420
  • Hetzel D J, Dent J, Reed W D. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95: 903–12
  • Hetzel D J, Dent J. Oesophageal disease. Recent Adv Gastroenterol 1988; 47: 261–89
  • Zeitoun P, Rampal P, Barbier P, Isal J P, Eriksson S, Carlsson R. Omeprazole (20 mg daily) compared to ranitidine (150 mg twice daily) in the treatment of esophagitis caused by reflux. Results of a double-blind, randomized multicenter trial in France and Belgium. Gastroenterol Clin Biol 1989; 13: 457–62
  • Sandmark S, Carlsson R, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study. Scand J Gastroenterol 1988; 23: 625–32
  • Havelund T, Laursen L S, Skoubo-Kristensen E, et al. Omeprazole and ranitidine in treatment of reflux oesophagitis: double-blind comparative trial. Br Med J 1988; 296: 89–92
  • Vantrappen G, Rutgeerts L, Schurmans P, Coenegrachts J L. Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis. Dig Dis Sci 1988; 33: 523–9
  • Klinkenberg-Knol E C, Jansen J M, Festen H PM, Meuwissen S G, Lamers C B. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet 1987; 1: 349–51
  • Collen M J, Lewis J H, Benjamin S B. Gastric acid hypersecretion in refractory gastroesophageal reflux disease. Gastroenterology 1990; 98: 654–61
  • Miller L S, Vinayek R, Frucht H, Gardner J D, Jensen R T, Maton P N. Reflux esophagitis in patients with Zollinger-Ellison syndrome. Gastroenterology 1990; 98: 341–6
  • Maton P N. Omeprazole. N Engl J Med 1991; 324: 965–75
  • Hirschowitz B I. High prevalence of esophagitis in Zollinger-Ellison syndrome vs low prevalence in non-ZE DU with BAO > 15 meq/h. Gastroenterology 1990; 98: A59, Suppl
  • Hirschowitz B I. Apparent and intrinsic sensitivity to pen-tagastrin of acid and pepsin secretion in peptic ulcer. Gastroenterology 1984; 86: 843–51
  • Hirschowitz B I. A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in esophagitis. Gastroenterology 1991, In press
  • Helm J F. Esophageal acid clearance. J Clin Gastroenterol 1986; 8: 5–11, Suppl 1
  • Goldberg H I, Dodds W J, Gee S, Montgomery C, Zboralske F F. Role of acid and pepsin in acute experimental esophagitis. Gastroenterology 1969; 56: 223–30
  • Lanas A, Hirschowitz B I. Significant role of aspirin use in esophagitis. (Gastroenterology 1991; 100: A106, Suppl: J Clin Gastroenterol. In press

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.